Insider · CIK 0001714080
Ferreira Juan Camilo Arjona
officer
Files at OGN (Organon & Co.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +11,519 | $0.00 | $0 | 28,899 | Aug 12, 2025 |
| Aug 11, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -4,122 | $9.22 | $38k | 24,777 | Aug 12, 2025 |
| Aug 11, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -11,519 | $0.00 | $0 | 11,519 | Aug 12, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Common Stock | +8,865 | $0.00 | $0 | 20,552 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | FTax withholding Common Stock | -3,172 | $14.51 | $46k | 17,380 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | AGrant or award Stock Option (right to buy)derivative | +198,019 | $0.00 | $0 | 198,019 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | AGrant or award Restricted Stock Unitsderivative | +40,295 | $0.00 | $0 | 40,295 | Apr 2, 2025 |
| Mar 31, 2025 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -8,865 | $0.00 | $0 | 17,730 | Apr 2, 2025 |
| Nov 7, 2024 | OGN Organon & Co. | MOption exercise Common Stock | +6,446 | $0.00 | $0 | 13,987 | Nov 8, 2024 |
| Nov 7, 2024 | OGN Organon & Co. | FTax withholding Common Stock | -2,300 | $15.80 | $36k | 11,687 | Nov 8, 2024 |
| Nov 7, 2024 | OGN Organon & Co. | MOption exercise Restricted Stock Unitsderivative | -6,446 | $0.00 | $0 | 12,893 | Nov 8, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.